Brilliance completes tens of millions in Pre-A funding, leading innovation in continuous flow technology

Recently, Brilliance — an innovative enterprise in China's continuous flow and photochemical equipment and process solutions sector — officially announced the completion of a tens of millions Pre-A round of financing. This round was led by Marathon Venture Partners, which has deep expertise in the digital healthcare field. Phoenixtree Capital acted as the financial advisor for this transaction.

This financing not only marks a significant milestone in Brilliance's development journey but also demonstrates strong market confidence in the company's technological capabilities and commercial potential within the intelligent and green transformation of continuous flow and photochemical equipment.

Brilliance is a technology-driven enterprise with innovation at its core. It has established a product R&D center and a demonstration facility in Yuhang District, Hangzhou, Zhejiang, as well as an intelligent manufacturing base in Ningbo, Zhejiang, covering a total production and R&D area of 3,000 square meters. As a leading player deeply engaged in the field of continuous flow and photochemical high-end equipment, Brilliance has developed a comprehensive solution covering the entire chain from "laboratory-scale testing → pilot-scale trials → industrial production," forming a unique integrated service model of "equipment + process + consumables."

At the level of the technical R&D team, Brilliance was founded by partners who are experts in photochemistry and continuous flow from top Chinese universities such as Zhejiang University, Fudan University, and East China University of Science and Technology. Brilliance has assembled a core technical R&D team led by seasoned experts in continuous flow intelligent equipment and fine chemistry, with team members averaging over 10 years of industry experience. They possess a deep understanding of the full-cycle challenges in chemical R&D and production systems. Leveraging technological investment in continuous processes, Brilliance's self-developed continuous synthesis equipment achieves efficient and precise control of reaction conditions, reducing traditional experimental cycles by over 60%. This enables unmanned and intelligent operation of chemical experiments, enhancing safety and efficiency while lowering labor and raw material costs for enterprises by 40%. It effectively addresses industry pain points in fine chemical R&D such as "low efficiency, high costs, and poor reproducibility." The relevant equipment has been field-validated by leading chemical companies including China Petrochemical Corporation, Zhejiang NHU, and Capchem, demonstrating significant application value in university research institutes, fine chemicals, high-end pharmaceutical intermediates, new materials, new energy, and other fields.

In terms of market expansion, Brilliance has initially established a nationwide service network, setting up offices in key regions across China, including East, Central, South, North, Southwest, and Northwest China. Its services cover over a hundred enterprise clients in multiple critical sectors such as new energy, pharmaceuticals, and new materials. Thanks to its reliable product performance and professional technical support, Brilliance has established long-term partnerships with several industry leaders and renowned Chinese universities, continuously strengthening its market recognition in specialized segments.

Regarding the core use of this round of financing, Dr. Hua Chaojun, Founder and CEO of Brilliance, stated: "The funds raised will be strategically allocated across three key areas—technological iteration, market expansion, and production capacity enhancement—to comprehensively strengthen the company's core competitiveness and industry service capabilities:

Accelerating Core Technology R&D:

Resources will be directed toward the iterative upgrading of next-generation continuous flow reaction equipment and intelligent photochemical devices, with a focus on breakthroughs in equipment miniaturization and precise control technologies. Efforts will also enhance industrial-scale equipment and process solutions for key target markets.

Optimizing Production Capacity and Supply Chain Systems:
We will establish standardized and intelligent production workshops, strictly control the quality of components, streamline core parts manufacturing processes, and shorten equipment delivery cycles to meet customer needs for rapid deployment of R&D and production projects.

Strengthening Market Expansion Efforts:
By deepening channel development and brand promotion, we will form specialized service teams to carry out targeted marketing in emerging fields such as new energy and new materials. Increased investment in pre-sales and after-sales services will further elevate brand recognition and influence.

Deepening Overseas Market Strategy:
We aim to shift from displacing overseas products in the Chinese market to capturing market share abroad. This will involve boosting overseas promotional efforts and exploring new avenues for growth in international markets."

Currently, China's petrochemical and chemical industry has become a pillar of the national economy, accounting for 14.9% of industrial value-added in 2024. However, the industry also faces challenges such as insufficient supply of high-end fine chemicals and relatively low R&D efficiency. Against this backdrop, the government has introduced a series of policies to support industry upgrading. 

Brilliance is deeply aligned with these industry trends. Leveraging this round of financing as an opportunity, the company will continue to strengthen its technological expertise in continuous chemistry and photochemistry, promoting the deep integration of equipment and digital technologies to help clients achieve digitalized R&D and green production. Over the next three years, Brilliance aims to expand its client base to over 500 companies, focusing on addressing equipment demands in emerging fields such as new energy, new materials, and fine chemicals. Brilliance strives to capture over 20% of the market share in the continuous flow reaction equipment segment and plans to initiate a new round of financing at an appropriate time to accelerate its international expansion.

Driven by both policy tailwinds and capital support, Brilliance is steadily progressing toward its goal of becoming a "leading enterprise in intelligent continuous flow equipment." It is poised to inject strong momentum into the high-quality development of China's petrochemical and chemical industry.